Board of Directors

All members of the Solve ME/CFS Initiative (Solve M.E.) Board of Directors have a personal relationship with the disease. They are either patients themselves or have a family member who suffers from it. This intimate connection furthers their commitment to making ME/CFS understood, diagnosable, and treatable.

John NicolsJohn Nicols, Redwood City, CA, President/CEO, Codexis Inc. – Solve M.E. Board Chair. John currently serves as President and CEO of Codexis Inc. (; Nasdaq:CDXS), a leading San Francisco Bay Area biotechnology company that engineers and markets proprietary proteins for the world’s pharmaceutical industry. John started as CEO of Codexis in June of 2012 and also serves on the publicly listed company’s board of directors.

Prior to Codexis, John held roles of increasing responsibility over a 22-year career at Albemarle Corporation (NYSE: ALB), a globally leading specialty chemical company headquartered in Baton Rouge, Louisiana. Before leaving Albemarle, John was responsible for the corporation’s strategic development department as well as the company’s flagship $1+ billion global catalyst business. During his tenure at Albemarle, John and his family resided for three years in Tokyo.

A native of New York City, John earned an MBA from the MIT Sloan School of Management, and a Bachelor of Science in Chemical Engineering from the NYU Polytechnic University. John has served on numerous trade association Boards during his extensive career, including currently serving on the board of directors of BayBio, the premier biotechnology industry association in the San Francisco Bay Area.

John is married with two children and four grandchildren. His wife, Marcie, has suffered for over 20 years with Myalgic Encephalomyelitis (ME/CFS) and Fibromyalgia.


Barbara N. Lubash, Corona Del Mar, CA – Solve M.E. Board Vice Chair. Barbara is a Director and Advisor for corporate and non-profit boards. She serves on boards of HicuityHealth, Clew Medical, and CareConnectMD. Ms. Lubash is a member of the Mass General Brigham Innovation Growth Board, the Health Policy and Management Executive Council of the Harvard T.H. Chan School of Public Health, and the STEM Advantage Advisory Board. In her prior careers as a health care executive, and later as a venture capitalist, Ms. Lubash led and advised innovative healthcare technology and service organizations. She was co-founder and Managing Director of Versant Ventures, and before that a Venture Partner at Crosspoint Ventures. Prior corporate boards include CodeRyte (acq 3M), Cogent Healthcare (acq Sound Physicians), Redbrick Health (acq Virgin Pulse), Titan Health (acq USPI), and Vantage Oncology (acq McKesson). She was Board Chair of the California HealthCare Foundation where she earlier led the formation of the Foundation’s PRI Impact Investment strategy (Innovation Fund). Ms. Lubash held management roles at PacifiCare (acq United), PHCS (a PPO), Hewlett Packard, and the Harvard Community Health Plan (Harvard Pilgrim). She received a BS from Tufts University, and a Master’s in Health Policy and Management from Harvard Chan School of Public Health. Ms. Lubash completed Board of Directors training at Stanford Directors College, and is a member of the Corporate Directors Roundtable of Orange County and the National Association of Corporate Directors.



Michael Atherton, Arlington, VA – Solve M.E. Board Treasurer.  Mike is the founder and principal of the management consulting firm Latitude Associates.  His background is in application software and eBusiness technologies combined with operations management experience and strategic planning skills.  He was one of four initial team members of xTuple LLC, an Enterprise Resources Planning software firm, graduating the firm from incubation stage to the world’s leading open source ERP software company. Mike lives in Arlington, Virginia with his wife Christine.  They met at William and Mary where both were athletes – Mike played football and Christine was on the softball team.  After graduating, they both received their MBAs.  Soon after Christine started working, however, she became ill with ME/CFS.  Mike schooled himself in the research and issues surrounding ME/CFS and eventually found our organization.  For the last several years, both Mike and his parents have been stalwart supporters of our work.


Rick Sprout new photoRick Sprout, Fairfax, VA, DMI – Solve M.E. Board Secretary. Rick is currently a Director of Civilian Sales at DMI. Prior to joining DMI he was with IBM for over 14 years. Rick retired from the Marine Corps as a Major in September 1996. He started his Marine Corps career as an Infantry Officer stationed at Twenty Nine Palms California. He later transitioned to become a Communications Officer, upon his retirement from the Pentagon Navy staff in 1996. He holds a bachelor’s degree from Western Michigan University.

Rick and his wife Barbara have been active supporters of Solve M.E. since Rick’s brother Greg was diagnosed in 2004. Solve M.E. gave them significant information and insight when Greg was first diagnosed and has provided a network of medical insights assisting Greg in his ongoing medical challenges. In addition to support of his brother, Barbara and Rick are supporters of the Helping Children Worldwide organization making a difference in the lives of children and women in Sierra Leone. In addition to other philanthropic support for children in Nakuru, Kenya and Rwanda. Rick and Barbara are active in their local Northern Virginia community as well.

As residents of the Washington DC area, Rick and Barbara look forward to enhancing the advocacy through our government to truly solve ME/CFS, providing a better future for others at an early onset of the disease. They support research initiatives that will find the answers to return Greg and others to fully active and productive lives.


Oved Amitay is the Chief Executive Officer at Solve M.E. He has dedicated most of his professional career to the development of life-changing therapeutic options for people affected by rare genetic diseases.

Throughout his career, Oved had extensive engagements with healthcare systems and patient advocacy organizations around the world, forging collaborations to address the needs of people affected by rare genetic diseases. Oved is frequently invited to speak on topics related to orphan drugs, the development and commercialization of therapies for patients with rare diseases.

Oved is a registered pharmacist, trained at the School of Pharmacy, Hebrew University in Jerusalem, and holds a M.Sc. in Pharmacology from Northeastern University in Boston. He has a certificate from the program for Critical and Creative Thinking at the University of Massachusetts Boston. Oved also has more than twenty years of leadership experience as an officer in the Israeli Defense Forces.

Oved served as Chief Business Officer at CENTOGENE (NASDAQ: CNTG), a global leader in the diagnostics of rare hereditary disorders where Hhs overall responsibility for the company´s programs with the biotechnology and pharmaceutical industry included enhancing existing partnerships and establishing new collaborations to facilitate drug development and improve treatment outcomes.

Oved joined CENTOGENE from Arrett Neuroscience, where he held the position of President and Chief Operating Officer, having led the company’s strategy for developing therapies for Rett syndrome. Prior to that, he served as Vice President, Head of Commercial at Alnylam Pharmaceuticals (NASDAQ: ALNY), where he played a lead role in the organization’s transition from a technology-platform focused company to a patient-centric drug development and pre-launch enterprise. Oved had a long tenure at Genzyme Corporation (now Sanofi Genzyme) as Vice President, Strategic Development, responsible for program management, business development, market assessment, and business planning for the rare genetic diseases franchise. Prior to that position, he was General Manager of the Gaucher Disease and MPS Portfolios, where he was responsible for the flagship product Cerezyme®, leading it to peak sales of over $1.2 billion. He also oversaw the development of the drug Eliglustat, which was approved by the FDA and EMA for the treatment of Gaucher Disease. Oved joined Genzyme in 1998 and held positions of increasing responsibility in regulatory affairs, marketing, and business development in Europe and the Middle East. Prior to joining Genzyme, he was a staff pharmacologist at Peptor Ltd. (Israel) and Cambridge NeuroScience, Inc. (MA, USA), where he was involved in early-stage drug development programs.

He is also a Founding Advisor of Splisense Therapeutics, Israel.


Vicki Boies, PsyD, Chicago, IL.  Vicki Boies and her husband, Bill, have been active supporters of the Solve ME/CFS Initiative since 1995, out of concern for a close family member who has been ill for more than 20 years. Vicki received her Bachelor of Arts magna cum laude from Brown University, her Master of Arts from the University of Chicago School of Social Service Administration and her doctorate in clinical psychology from the Illinois School of Professional Psychology, where she was on the faculty for several years. Vicki spent most of her career as a clinical psychologist in private practice in Chicago before retiring in 2010. Prior to joining the board, she served on numerous local boards and commissions, including most recently as president of a community mental health board with taxing and grant-giving authority.


Carol-NewCarol Head, Los Angeles, CA. – Carol Head joined Solve M.E. as President and CEO in October 2013 and retired from the position in May 2019. Carol experienced ME/CFS for many years and is largely recovered. Carol is an executive with more than 25 years of success in both the for-profit and nonprofit sectors. She’s an experienced business owner, corporate executive, communicator and problem-solver. In the private sector, she most recently served as CEO of two companies. Previously, she served as vice president of marketing for two Internet-based companies. Carol also spent eight years as an executive at the Los Angeles Times in a variety of marketing and strategy roles. She served as associate vice president of the 1984 Los Angeles Olympic Organizing Committee. Carol has been active in community affairs with an emphasis on human rights for women and girls and amelioration of extreme poverty, serving on three national nonprofit boards, including service as a board chair. Carol is a founder of Project Redwood (, a venture philanthropy fund that supports creative approaches to alleviating extreme global poverty. She received a Bachelor of Arts in English from Wellesley College, and earned an MBA from Stanford University. Carol is married and has two sons in their mid-20s.



Bill Hassler, Washington, DC, Steptoe & Johnson LLP. William (Bill) Hassler is a partner at Steptoe & Johnson LLP, one of the leading litigation firms world-wide. Prior to joining the firm’s Washington DC office, Bill served as a prosecutor for the Office of Independent Counsel investigating the Iran/Contra affair, and in the Environmental Crimes Section of the US Department of Justice.  He is a former Special Assistant to the Director of the Federal Bureau of Investigation (FBI). Bill received his J.D. from Yale Law School and his B.A. in International Studies from University of North Carolina at Chapel Hill. Bill joined the Solve ME/CFS Initiative after his nephew, Tom Camenzind, a former student at Stanford University, became severely ill and bedbound as a result of ME/CFS.


Janice Stanton, Harrison, NY. Janice joined the Solve M.E. board of directors for a loved one who is afflicted with ME/CFS. Ms. Stanton is a founding member and President of Contrarian Capital Management, LLC. She has 30 years of experience in distressed securities. Prior to co-founding Contrarian, Ms. Stanton was the Founder and Head of the Bank Debt and Trade Claims desk at Oppenheimer & Co. She was an Associate in the Corporate Finance Department of Lehman Brothers (“Lehman”). Prior to business school, Ms. Stanton was an Analyst with Booz Allen Hamilton, focusing on business strategy consulting. She has served on numerous bank debt committees, including Audio Visual Services, Pillowtex and Warnaco. She has also chaired and served on Official Committees of Unsecured Creditors. Ms. Stanton received her MBA from the Stanford University Graduate School of Business and graduated magna cum laude with a BS from The Wharton School of the University of Pennsylvania. Ms. Stanton is a CFA charter holder.


Andrea Bankoski, MPH, Chapel Hill, NC.  Andrea is a data manager at the University of North Carolina-Chapel Hill. She developed ME/CFS after contracting Epstein-Barr virus in 1995. Andrea has worked in public health and clinical research at the state and federal levels of government for over a decade. She specializes in leading data efforts to inform public health policy and implementing data governance to prioritize best practices for data quality, accessibility, analysis, and dissemination. Her work has been published in several peer-reviewed journals and disease surveillance reports. Andrea received her master’s degree in public health with a certificate in biostatistics from George Mason University and her bachelor’s degree from Pennsylvania State University.


Rona E. Kramer, Olney, MD. Rona was sworn in as Secretary of the Maryland Department of Aging on March 13, 2015, as a member of Governor Larry Hogan’s cabinet.  During her time as Secretary, she has focused on establishing Maryland as an attractive location for older adults through vibrant communities and supportive services that offer residents the opportunity to live healthy and meaningful lives.

Secretary Kramer is a lifelong resident of Montgomery County, Maryland.  She is a graduate of the University of Maryland, College Park and the University of Baltimore School of Law.  Secretary Kramer comes from a long career in both government service and business.

In November 2002, she was elected to the Maryland Senate, representing Montgomery County, and served for eight years.  She served on the Budget and Taxation Committee during her entire tenure, which included serving on the Capital Budget subcommittee and Pensions subcommittee.  During her tenure, she was a committed advocate for seniors.  She was a lead sponsor for bills establishing the Silver Alert Program, reverse mortgage protection for seniors, and protection of seniors from financial exploitation through the use of undue influence,

As Secretary of the Department of Aging, she leads the Department’s efforts in protecting the rights and quality of life of our elder residents, most importantly to provide the services necessary to allow them to age at home and in their community.  Her mantra for the older adults in our communities is to Live Well and Age Well.


Fern Oppenheim, Scarsdale, NY.  Fern is the President and founder of Applied Marketing Innovations, a marketing consulting firm. She is also the co-founder of a non-profit organization that helps various locales with branding, marketing and strategic communications.

In these capacities, she has worked with national organizations, educational groups, think tanks, communications experts, market research firms, government officials, tourism professionals, philanthropic foundations, media personalities, etc., and has been asked to speak at numerous national and international conferences.

She has an extensive marketing, media and management background with blue-chip advertising agencies such as Young & Rubicam and Fortune 500 companies.

She is the co-author of a math textbook.


Stewart Gittelman, Lloyd Neck, NY. Stewart was CEO of Advanced Care, Inc. (ACI), which he owned with his wife Nancy for 25 years. At the time of its sale in 2014, ACI was the largest, independently owned acute care home infusion provider in New York State. He sold ACI to a private equity firm in 2014 and it was subsequently sold (as part of a national platform) to a subsidiary of United Health Group (OptumRx) in 2015. At the time that Stewart sold the business, ACI consisted of approximately 180 employees and provided hi-tech nursing and pharmacy coverage throughout NY state.

Prior to ACI, Stewart was the owner and president of a sales and marketing company that specialized in consulting vertical software developers, throughout the nation, on how to sell relatively high ticket ($20,000 to $80,000) vertical software without face-to-face contact. While this is a common practice today, it was not very common in the 1980s.

Stewart is a classic small business entrepreneur with a great deal of experience managing and developing sales talent, clinical and administrative personnel, and problem-solving regarding strategic business concerns.

Stewart has lived in Lloyd Neck, NY with his wife Nancy since 2016. Stewart is 64 years of age. Their two children are 28 and 29 years of age. Stewart now enjoys managing his investments, mountain biking, sailing and skiing. He received his BA in philosophy from the University of Massachusetts at Amherst in 1978.


Gurdyal Kalsi, MD, MFPM, Baltimore, MD. Gurdyal is a seasoned executive in the pharmaceutical industry with over 22 years in Global transformational R&D leadership responsibilities resulting in several human medicinal products in-clinic and subsequent commercialization. He has held multiple executive leadership positions over the years and remains active on various technology, healthcare and faculty advisory panels globally.

Gurdyal is a specialist in pharmaceutical medicine with initial training in internal medicine and critical care medicine. He earned his MFPM from the UK Joint Royal Colleges of Physicians and Medical degrees in Medicine & Surgery from the Glancy Medical School.

He has been a Principal Investigator and Program Director on several clinical studies.
Gurdyal is intimately engaged in SARS CoV2 ARDS and Long COVID syndrome. He started his industry career in the development of CNS treatment strategies.

Visit his LinkedIn here.

Karl Zeile
, Los Angeles, CA

Amrit Shahzad
, San Diego, CA